by Menkes disease is a rare inherited disorder affecting copper metabolism and transport in the body. It is caused by mutations in a gene called ATP7A that provides instructions for making a protein also called ATP7A. This protein plays a vital role in distributing copper in the body and brain. Without sufficient copper, connective tissues and blood vessels weaken and develop abnormalities. People with Menkes disease typically have sparse, soft hair (kinky hair); jaundice or yellowish skin and eyes (jaundice); failure to thrive; vomiting; diarrhea; and seizures. The Menkes Disease Market is driven by the rising prevalence of rare diseases and growing product pipeline.
The Menkes Disease Market is estimated to be valued at US$ 165.1 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Menkes disease market are Fortress Biotech, Inc.,Teva Pharmaceutical Industries Ltd., Amerigen Pharmaceuticals Limited, Mylan N.V., Bausch Health Companies Inc.
The rising public awareness about rare diseases and government support in the form of orphan drug regulations are offering new opportunities in the Menkes disease market.
Given the small patient population, companies are focusing on expanding their rare disease business globally through partnerships and acquisitions to tap growing patient base in various countries.
Market Drivers
Growing research and development activities: Continuous research to understand the pathophysiology of Menkes disease and develop improved treatment options is driving the market growth. Several clinical trials are being conducted to evaluate new drug candidates.
Increasing healthcare expenditures: Rising healthcare spending by governments worldwide on rare disease treatment is supporting the market growth. Availability of healthcare coverages for such disorders makes treatment affordable.
PEST Analysis
Political: Recent regulations and healthcare reforms related to orphan diseases may positively impact market growth.
Economic: Rising disposable incomes in developing regions create opportunities for market players.
Social: Growing patient support groups help raise awareness and funding for rare diseases like Menkes Disease.
Technological: Advancements in genetic testing and therapies like gene replacement offer promise for better diagnosis and management of the condition. Researchers are working on new delivery methods for gene therapy to cross the blood–brain barrier.
Regions Of Concentration
North America currently represents the largest market for Menkes Disease treatment in terms of value, owing to established healthcare systems and high adoption of advanced therapies. The U.S. accounts for the major share within the region due to the presence of key players and favorable reimbursement policies.
Fastest Growing Region
The Asia Pacific region is expected to witness the fastest growth over the forecast period. This can be attributed to factors such as growing economies, increasing healthcare spending, and expanding patient access to diagnosis and treatments in countries like China, India and Japan. Rising awareness is also boosting early diagnosis and management in the region.
What Are The Key Data Covered In This Menkes Disease Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Menkes Disease Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Menkes Disease Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Menkes Disease Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Menkes Disease Market vendors
FAQ’s
Q.1 What are the main factors influencing the Menkes Disease Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Menkes Disease Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Menkes Disease Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Vaagisha Singh
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. LinkedIn
